Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 6
Submit an article Journal homepage
773
Views
36
CrossRef citations to date
0
Altmetric
Drug Evaluations

Tolvaptan for the treatment of heart failure: a review of the literature

Andrew Ambrosy Northwestern University, Feinberg School of Medicine, Center for Cardiovascular Innovation, Chicago, IL 60611, USA
,
Steven R Goldsmith University of Minnesota, Hennepin County Medical Center, Minneapolis, MN, USA
&
Mihai Gheorghiade Cardiovascular Center for Drug Development, Duke University, Director of Experimental Therapeutics, Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, 645 North Michigan Ave, Suite 1006, Chicago, IL 60611, USA +1 312 695 0051; +1 312 695 1434; [email protected]
, MD
Pages 961-976 | Published online: 15 Mar 2011

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luna Gargani, Philip H Schmidt & Mihai Gheorghiade. (2011) Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion. Expert Review of Cardiovascular Therapy 9:12, pages 1505-1513.
Read now

Articles from other publishers (35)

Yasuhiro Matsuda, Tadaaki Koyama, Kazufumi Yoshida, Shigeki Koizumi, Ken Nakamura, Masanosuke Ishigami, Hideki Tsubota & Genichi Sakaguchi. (2022) Effects of Low-Dose Tolvaptan for Fluid Management After Cardiovascular Surgery. Circulation Reports 4:12, pages 563-570.
Crossref
Shiro Komiya, Mari Katsumata, Moe Ozawa, Tatsuya Haze, Rina Kawano, Yuki Ohki, Shota Suzuki, Yusuke Kobayashi, Akira Fujiwara, Sanae Saka, Kouichi Tamura & Nobuhito Hirawa. (2022) Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial. Clinical and Experimental Nephrology 26:9, pages 851-858.
Crossref
Fukuko Nagura, Akihisa Kataoka, Ruri Ishibashi, Miho Mitsui, Hirofumi Hioki, Masanari Kuwabara, Kiyoko Uno, Yusuke Watanabe, Naoyuki Yokoyama & Ken Kozuma. (2021) Effect of oral tolvaptan for 1 year in patients with functional mitral regurgitation. Heart and Vessels 37:3, pages 434-442.
Crossref
Yasuhiro Hitomi, Yuji Nagatomo, Midori Yukino, Yusuke Yumita, Kazuki Kagami, Risako Yasuda, Takumi Toya, Takayuki Namba, Nobuyuki Masaki, Hirotaka Yada & Takeshi Adachi. (2021) Characterization of tolvaptan response and its impact on the outcome for patients with heart failure. Journal of Cardiology 78:4, pages 285-293.
Crossref
Yoshinobu Nakamura, Yuichirou Kishimoto, Shingo Harada, Takeshi Onohara, Yuki Otsuki, Hiromu Horie & Motonobu Nishimura. (2020) Tolvaptan can limit postoperative paroxysmal atrial fibrillation occurrence after open-heart surgery. Surgery Today 50:8, pages 841-848.
Crossref
Larry X. Nguyen & Benjamin Kohl. 2020. Evidence-Based Practice of Critical Care. Evidence-Based Practice of Critical Care 366 370.e1 .
Miho Mitsui, Akihisa Kataoka, Yugo Nara, Fukuko Nagura, Hideyuki Kawashima, Hirofumi Hioki, Makoto Nakashima, Yusuke Watanabe, Naoyuki Yokoyama & Ken Kozuma. (2019) Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow and normal-flow severe aortic stenosis. Heart and Vessels 34:10, pages 1684-1691.
Crossref
Yasunori Iida, Akihiro Yoshitake & Hideyuki Shimizu. (2019) Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement. Annals of Vascular Surgery 56, pages 103-107.
Crossref
Yuki Ikeda, Takayuki Inomata, Keisuke Kida, Yugo Shibagaki, Naoki Sato, Tohru Izumi & Junya Ako. (2018) Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. Heart and Vessels 34:3, pages 442-451.
Crossref
M Ohno. (2018) The pathophysiology of chronic cardiorenal disease based on central hemodynamics. Journal of Cardiovascular Medicine and Cardiology, pages 027-035.
Crossref
M Ohno. (2018) Renal congestion related to worsening renal function in patients with acute decompensated heart failure: Diuretic strategy for acute cardiorenal syndrome. Archives of Clinical Nephrology, pages 012-017.
Crossref
Jonathan Sen, Erin Chung & Darryl McGill. (2018) Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation 27:8, pages 928-939.
Crossref
Gustavo Rodrigues, António Tralhão, Carlos Aguiar, Pedro Freitas, António Ventosa & Miguel Mendes. (2018) Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?. Revista Portuguesa de Cardiologia (English Edition) 37:6, pages 491-496.
Crossref
Gustavo Rodrigues, António Tralhão, Carlos Aguiar, Pedro Freitas, António Ventosa & Miguel Mendes. (2018) Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?. Revista Portuguesa de Cardiologia 37:6, pages 491-496.
Crossref
Igor Ukrainets, Lyudmila Sidorenko, Mykola Golik, Igor Chernenok, Lina Grinevich & Alexandra Davidenko. (2018) N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output. Scientia Pharmaceutica 86:2, pages 12.
Crossref
Shuichi Kitada, Shohei Kikuchi, Takeshi Tsujino, Tohru Masuyama & Nobuyuki Ohte. (2018) The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study. ESC Heart Failure 5:1, pages 36-45.
Crossref
Yuichiro Kishimoto, Yoshinobu Nakamura, Shingo Harada, Takeshi Onohara, Satoru Kishimoto, Tomohiro Kurashiki, Yoshikazu Fujiwara & Motonobu Nishimura. (2018) Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery?　― Results of a Single-Center Randomized Controlled Study ―. Circulation Journal 82:4, pages 999-1007.
Crossref
Sujata Chakravarti & Melissa Busovsky-McNeal. (2016) Use of Tolvaptan in a Patient With Palliated Congenital Heart Disease. World Journal for Pediatric and Congenital Heart Surgery 9:1, pages 114-116.
Crossref
Jun-Ya Kaimori, Yoshitaka Isaka & Shiro Takahara. (2017) Tips for use of tolvaptan -From a nephrologist to gastroenterologists-. Kanzo 58:2, pages 85-90.
Crossref
Kazushi Terada, Kensuke Takagi, Itsuro Morishima & Hideyuki Tsuboi. (2017) Successful Medical Treatment Using Tolvaptan of Ventricular Septal Rupture Following Myocardial Infarction. Internal Medicine 56:18, pages 2435-2439.
Crossref
Kiyoshi Takasu, Tetsuro Miyazaki, Kanako Negoro, Shoichiro Yatsu, Megumi Shimizu, Azusa Murata, Takao Kato, Shoko Suda, Masaru Hiki, Takatoshi Kasai, Katsumi Miyauchi & Hiroyuki Daida. (2017) Successful Treatment of Congestive Heart Failure Due to Severe Aortic Valve Stenosis With Low Dose Tolvaptan in Elderly Patients. International Heart Journal 58:3, pages 378-384.
Crossref
Shuichi Kitada, Shohei Kikuchi, Hiroo Sonoda, Atsuhiro Yoshida & Nobuyuki Ohte. (2016) Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure. Journal of International Medical Research 44:6, pages 1430-1442.
Crossref
Keisuke Shimizu, Kent Doi, Teruhiko Imamura, Eisei Noiri, Naoki Yahagi, Masaomi Nangaku & Koichiro Kinugawa. (2015) Ratio of urine and blood urea nitrogen concentration predicts the response of tolvaptan in congestive heart failure. Nephrology 20:6, pages 405-412.
Crossref
Takamasa Ohki. (2015) Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World Journal of Hepatology 7:12, pages 1685.
Crossref
Giorgio Graziani, Daniela Pini, Silvia Oldani, David Cucchiari, Manuel Alfredo Podestà & Salvatore Badalamenti. (2013) Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists. Heart Failure Reviews 19:6, pages 699-708.
Crossref
Il Hwan OhGheun-Ho Kim. (2014) Clinical Application of V2 Receptor Antagonists. Korean Journal of Medicine 86:6, pages 686.
Crossref
K Kinugawa, T Imamura & I Komuro. (2013) Experience of a Vasopressin Receptor Antagonist, Tolvaptan, Under the Unique Indication in Japanese Heart Failure Patients. Clinical Pharmacology & Therapeutics 94:4, pages 449-451.
Crossref
Joseph G. Verbalis, Steven R. Goldsmith, Arthur Greenberg, Cynthia Korzelius, Robert W. Schrier, Richard H. Sterns & Christopher J. Thompson. (2013) Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations. The American Journal of Medicine 126:10, pages S1-S42.
Crossref
Richard H. Sterns, John K. Hix & Stephen M. Silver. (2013) Management of Hyponatremia in the ICU. Chest 144:2, pages 672-679.
Crossref
M. A. Konstam, P. S. Pang & M. Gheorghiade. (2011) Seeking new heights in acute heart failure syndromes: lessons from ASCEND and EVEREST. European Heart Journal 34:18, pages 1345-1349.
Crossref
David E. LanfearHani N. SabbahSteven R. GoldsmithStephen J. GreeneAndrew P. AmbrosyAngela J. FoughtMary J. KwasnyKarl SwedbergClyde W. YancyMarvin A. KonstamAldo P. MaggioniFaiez ZannadMihai Gheorghiade. (2013) Association of Arginine Vasopressin Levels With Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. Circulation: Heart Failure 6:1, pages 47-52.
Crossref
Richard H. Sterns, Stephen M. Silver & John K. Hix. 2013. Hyponatremia. Hyponatremia 221 250 .
I. V. Ukrainets & N. L. Bereznyakova. (2012) Heterocyclic diuretics. Chemistry of Heterocyclic Compounds 48:1, pages 155-165.
Crossref
Susan E. Shoaf, Suresh Mallikaarjun & Patricia Bricmont. (2011) Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects. European Journal of Clinical Pharmacology 68:2, pages 207-211.
Crossref
Kyung W. Park. (2012) Nonsurgical Therapy for Heart Failure. International Anesthesiology Clinics 50:3, pages 1-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.